Last updated on October 2017

Feasibility Study on LITT for Newly Diagnosed Glioblastoma


Brief description of study

Multicenter, open-label, prospective designed study to characterize the performance of brain laser interstitial thermal therapy (LITT) ablation using the Monteris NeuroBlate System in combination with standard of care radiation therapy and temozolomide for the treatment of newly diagnosed glioblastomas (GBM).

Clinical Study Identifier: NCT02880410

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Roy Strowd, MD

Wake Forest School of Medicine
Winston-Salem, NC United States
  Connect »

Alireza Mohammadi, MD

Cleveland Clinic Foundation
Cleveland, OH United States
  Connect »